CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Graft Polymer (UK) Plc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Graft Polymer (UK) Plc
Central Working Victoria
Eccleston Yards 25
LONDON, SW1W 9NF  United Kingdom Ticker: GPLGPL
Business Summary
Graft Polymer (UK) Plc is a United Kingdom-based multi sector chemical company. The Company is engaged in offering modified alloyed and bio polymer solutions for refiners, compounders, and processors. Its core business comprises polymer modification and the development of drug delivery systems. The Company offers bespoke, adapted, and tailored products for customer requests. Its products include GP impact modifiers for polyamide toughening, thermoplastic elastomers (TPE), PP-reinforced compounds, performance additives, polyvinyl chloride (PVC) products, polymeric alloys, vitrimers, wire & cable, non-woven, Halogen-free flame retardants products (HFFR), wood plastic composite board (WPC), recycling, hot melts, roto molding, block-copolymers, pipes, pet modification, porous products, anticorrosive coating, reinforced bioplastic, dispersants, nano graphene. The Company's subsidiaries include Graft Polymer d.o.o, Graft Polymer IP Limited, and GRAFTBIO Limited.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022Yes----

Industries
SIC Code Description
2821 Plastics materials, synthetic resins, and nonvulcanizable elastomers
2824 Manmade organic fibers, except cellulosic
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board NicholasNelson 3/15/2024 3/15/2024
Chief Executive Officer, Chief Technical Officer, Executive Director VictorBolduev 9/18/2017 9/18/2017
Chief Financial Officer, Executive Director YifatSteuer 12/21/2021 12/21/2021
Chief Marketing Officer, Executive Director PavelKobzev 5/25/2019 5/25/2019
Company Secretary AnthonyEastman 12/21/2021 5/18/2017

General Information
Outstanding Shares: 124,763,966 (As of 1/4/2024)
Stock Exchange: LON


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024